Načítá se...
Agomelatine in unipolar depression in clinical practice: a retrospective chart review
Agomelatine (Valdoxan), a synthetic melatonergic receptor agonist at the MT(1) and MT(2) receptors, was first used in the management of sleep disorder. Its 5HT2C receptor antagonistic properties support its antidepressant potential. It is currently licensed in the UK, Europe and USA for the treatmen...
Uloženo v:
| Hlavní autoři: | , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
SAGE Publications
2011
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3736909/ https://ncbi.nlm.nih.gov/pubmed/23983944 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2045125311423296 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|